Stepladder technique successful for malignant glaucoma

Article

Malignant glaucoma can be successfully managed using the stepladder technique, including timely and appropriate interventions, claims a paper in the journal Ophthalmology.

Malignant glaucoma can be successfully managed using the stepladder technique, including timely and appropriate interventions, claims a paper in the journal Ophthalmology.

Dr Paraaj Dave et al., L. V. Prasad Eye Institute, Hyderabad, India, reported the treatment outcomes in 28 eyes of 26 patients with malignant glaucoma between 1991 and 2009. The main outcome measures of the retrospective case series were IOP and central anterior chamber depth. Resolution was defined as eyes with an IOP of 21 mmHg or less and deepening of the central anterior chamber with or without topical anti-glaucoma medications.

The treatment algorithm consisted of anti-glaucoma medications and cycloplegics as first-line methods. The second-line therapies in pseudophakic eyes were laser hyaloidotomy and vitrectomy-hyaloidotomy-iridectomy (VHI) or transscleral cyclophotocoagulation (TSCPC).

Of the eyes studied, five were phakic and 23 were pseudophakic. Trabeculectomies were performed in 11 eyes, cataract surgery in 10 eyes and combined cataract and glaucoma surgery in 7 eyes.

The mean IOP decreased from 34±8.3 mmHg at presentation to 14.3±5.2 mmHg at the last follow up visit. Resolution of malignant glaucoma was seen in 27 eyes with 17 eyes resolved with one intervention and 10 eyes undergoing repeat procedures.

Medical treatment was advantageous in phakic eyes, laser hyaloidotomy was successful in pseudophakic eyes and vitrectomy and TSCPC was beneficial in refractory cases. The stepladder technique was successful in 96% of patients in the case series.

To read the abstract please click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.